Doctor profile · Federal record
Dr. Amanda Dehlendorf, M.D.
Internal Medicine Physician (CMS: Rheumatology) · Saint Louis, MO
- NPI 1871704270
- Accepts Medicare
- MIPS 98.5 / 100 · 2023
- 21 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
615 S New Ballas RD
Saint Louis, MO 631418221
(314) 569-6000 - Mailing address
-
820 Queen Anne Pl
Saint Louis, MO 631223144
Credentials & registration
- NPI registered
- May 2007 — 19 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 207R00000X — NUCC code
- State license (1)
- Missouri #2007002733
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1871704270. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
109,495
Distinct HCPCS
10
Medicare allowed
$1,227,758
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 42,326 | 11 | $6 | |
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 36,000 | 12 | $5 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 17,400 | 19 | $13 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 10,888 | 20 | $42 | |
36415 |
Insertion of needle into vein for collection of blood sample | 551 | 298 | $3 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 465 | 324 | $122 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 324 | 50 | $61 | |
84450 |
Liver enzyme (sgot), level | 257 | 161 | $5 | |
84460 |
Liver enzyme (sgpt), level | 257 | 161 | $5 | |
82565 |
Blood creatinine level | 252 | 158 | $5 |
In context: peer comparison
Among 216 peers in this city , average services per provider: 171. This provider delivers 640× the peer median.Open Payments
Industry payments received
All-time total
$649
Transactions
29
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 19 | $397.03 | |
| Janssen Biotech, Inc. | 1 | $99.00 | |
| GlaxoSmithKline, LLC. | 5 | $94.04 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $44.40 | |
| Amgen Inc. | 1 | $14.52 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,806
Patients
1,133
Total drug cost
$72,052
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 629 | 297 | $3,758 |
| Tramadol Hcl | Generic | 506 | 127 | $6,427 |
| Hydroxychloroquine Sulfate | Generic | 336 | 154 | $17,438 |
| Methotrexate (Methotrexate Sodium) | Brand | 293 | 124 | $11,397 |
| Duloxetine Hcl | Generic | 139 | 52 | $2,337 |
| Pregabalin | Generic | 126 | 23 | $3,874 |
| Celecoxib | Generic | 124 | 61 | $3,678 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 123 | 49 | $3,442 |
| Leflunomide | Generic | 111 | 52 | $7,106 |
| Meloxicam | Generic | 85 | 39 | $292 |
Hospital affiliations
Frequently asked questions
What is Dr. Amanda Dehlendorf's medical specialty?
Dr. Amanda Dehlendorf practices Internal Medicine Physician in Saint Louis, MO.
Where does Dr. Amanda Dehlendorf practice?
Dr. Amanda Dehlendorf practices at 615 S New Ballas RD, Saint Louis, MO 631418221. Office phone: 3145696000.
What is Dr. Amanda Dehlendorf's NPI?
Dr. Amanda Dehlendorf's National Provider Identifier (NPI) is 1871704270, issued by NPPES.
Does Dr. Amanda Dehlendorf accept Medicare assignment?
Yes. Dr. Amanda Dehlendorf accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Amanda Dehlendorf commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.